Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to -$11.8 million.

  • Orthopediatrics' Consolidated Net Income fell 4866.78% to -$11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.6 million, marking a year-over-year decrease of 6036.42%. This contributed to the annual value of -$37.8 million for FY2024, which is 8032.8% down from last year.
  • Orthopediatrics' Consolidated Net Income amounted to -$11.8 million in Q3 2025, which was down 4866.78% from -$7.1 million recorded in Q2 2025.
  • Over the past 5 years, Orthopediatrics' Consolidated Net Income peaked at $18.5 million during Q3 2022, and registered a low of -$16.1 million during Q4 2024.
  • Its 5-year average for Consolidated Net Income is -$5.4 million, with a median of -$6.8 million in 2023.
  • Within the past 5 years, the most significant YoY rise in Orthopediatrics' Consolidated Net Income was 94383.25% (2022), while the steepest drop was 1100000.0% (2022).
  • Over the past 5 years, Orthopediatrics' Consolidated Net Income (Quarter) stood at $72000.0 in 2021, then tumbled by 11000.0% to -$7.8 million in 2022, then rose by 14.74% to -$6.7 million in 2023, then tumbled by 140.16% to -$16.1 million in 2024, then grew by 26.73% to -$11.8 million in 2025.
  • Its last three reported values are -$11.8 million in Q3 2025, -$7.1 million for Q2 2025, and -$10.7 million during Q1 2025.